Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma.

IF 0.7 4区医学 Q3 OTORHINOLARYNGOLOGY

Ent-Ear Nose & Throat Journal Pub Date : 2025-10-01 Epub Date: 2023-01-02 DOI:10.1177/01455613221150121

Hayri Ogul, Alper Kiziloglu, Yasemin Ogul

引用次数: 0

Abstract

Significance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES.

查看原文本刊更多论文

喉癌患者出血性后可逆性脑病综合征

意义陈述后期可逆性脑病综合征（PRES）的特点是神经系统症状多变，如头痛、精神状况恶化、意识丧失和视力减退。这种疾病会导致脑血流自动调节功能受损。5羟色胺（5HT-3）受体拮抗剂昂丹司琼可能会导致出血性 PRES。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ent-Ear Nose & Throat Journal 医学-耳鼻喉科学

CiteScore

3.20

自引率

0.00%

发文量

385

审稿时长

6-12 weeks

期刊介绍： Ear, Nose & Throat Journal provides practical, peer-reviewed original clinical articles, highlighting scientific research relevant to clinical care, and case reports that describe unusual entities or innovative approaches to treatment and case management. ENT Journal utilizes multiple channels to deliver authoritative and timely content that informs, engages, and shapes the industry now and into the future.